Acetylglutamic Acid

Acetylglutamic Acid

SCHEMBL82128

CC(=O)N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 8/20 0.69
NAALAD2 Q9Y3Q0 3/20 0.69
RIMKLA Q8IXN7 1/20 0.69
KDM4E B2RXH2 1/20 0.57
MAPT P10636 1/20 0.57
THRB P10828 1/20 0.57
ALOX15 P16050 1/20 0.57
NFKB1 P19838 1/20 0.57
PTGS2 P35354 1/20 0.57
THPO P40225 1/20 0.57
RECQL P46063 1/20 0.57
BLM P54132 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
ALDH1A1 P00352 1/20 0.55
GNPAT O15228 1/20 0.54
GGH Q92820 1/20 0.53
FNTA P49354 2/20 0.50
FNTB P49356 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetylglutamic Acid SCHEMBL2512801 1.00 FOLH1 (0.69) FOLH1NAALAD2RIMKLAKDM4EMAPT
Acetylglutamic Acid SCHEMBL716411 1.00 FOLH1 (0.69) FOLH1NAALAD2RIMKLAKDM4EMAPT
Aceglumate SCHEMBL198970 1.00 FOLH1 (0.69) FOLH1NAALAD2RIMKLAKDM4EMAPT
Acetylglutamic Acid SCHEMBL31621391 0.98 FOLH1 (0.67) FOLH1NAALAD2RIMKLAKDM4EMAPT
Aceglumate SCHEMBL11403040 0.98 FOLH1 (0.67) FOLH1NAALAD2RIMKLAKDM4EMAPT
Acetylglutamic Acid SCHEMBL11793383 0.98 FOLH1 (0.67) FOLH1NAALAD2RIMKLAKDM4EMAPT
Acetylglutamic Acid SCHEMBL31621403 0.98 FOLH1 (0.67) FOLH1NAALAD2RIMKLAKDM4EMAPT
Acetylglutamic Acid SCHEMBL31621384 0.98 FOLH1 (0.67) FOLH1NAALAD2RIMKLAKDM4EMAPT
Acetylglutamic Acid SCHEMBL11403051 0.98 FOLH1 (0.67) FOLH1NAALAD2RIMKLAKDM4EMAPT
Acetylglutamic Acid SCHEMBL11403044 0.98 FOLH1 (0.67) FOLH1NAALAD2RIMKLAKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4082 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP claimed
WO-2026098617-A1 RADIOPHARMACEUTICAL TARGETING CARBONIC ANHYDRASE IX PROTEIN 无锡诺宇医药科技有限公司 2026-05-15 WO claimed
US-20260131034-A1 RADIOPHARMACEUTICALS TARGETING CARBONIC ANHYDRASE IX PROTEINS NORROY BIOSCIENCE CO LTD (CN) 2026-05-14 US claimed
CN-122005829-A Tobramycin-polymyxin conjugated compound and preparation method and application thereof 诺海医康(苏州)生物技术有限公司 2026-05-12 CN claimed
WO-2026087109-A1 PERSONAL CARE COMPOSITION BASED ON AN ACETYL AMINOACID COMPOUND AND A CYSTINE COMPOUND UNILEVER IP HOLDINGS B.V. (NL) 2026-04-30 WO claimed
US-20260083860-A1 COMPOSITIONS AND METHODS FOR GENOME EDITING POSEIDA THERAPEUTICS INC (US) 2026-03-26 US claimed
US-12584924-B2 Compositions and methods for diagnosing and treating chronic kidney disease SOCIETE DES PRODUITS NESTLE S.A. (CH) 2026-03-24 US claimed
CN-121577901-A Urine metabolism marker combination for distinguishing benign kidney diseases from kidney cancers and application thereof 哈尔滨脉图精准技术有限公司 2026-02-27 CN claimed
US-20260042732-A1 Sulfur-containing Compounds and Compositions Thereof for Delivery of Nucleic Acids POSEIDA THERAPEUTICS INC (US) 2026-02-12 US claimed
EP-4683643-A1 STRATEGIES FOR KNOCK-INS AT AAVS1 SAFE HARBOR SITES Emendobio Inc. (US) 2026-01-28 EP claimed
WO-1992002257-A2 RENAL-SELECTIVE ANGIOTENSIN II ANTAGONISTS FOR TREATMENT OF HYPERTENSION G.D. SEARLE & CO. (US) 1992-02-20 WO claimed
WO-1992001667-A1 RENAL-SELECTIVE PRODRUGS FOR CONTROL OF RENAL SYMPATHETIC NERVE ACTIVITY IN THE TREATMENT OF HYPERTENSION G.D. SEARLE & CO. (US) 1992-02-06 WO claimed
EP-0243322-B1 COMPOUNDS CONTAINING BIOAVAILABLE IRON, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM MAGIS FARMACEUTICI S.P.A. (IT) 1992-01-29 EP claimed
EP-0452000-A2 Preparation of optically active norbornyl amine derivatives SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) 1991-10-16 EP claimed
US-4883786-A CARDIOTROPIC AGENTS MAGIS FARMACEUTICI SRL (IT) 1989-11-28 US claimed
EP-0313692-A1 Process for synthesis of glumatic acid from acrylate, amide and synthesis gas TEXACO DEVELOPMENT CORPORATION (US) 1989-05-03 EP claimed
EP-0167115-B1 NEW DERIVATIVES OF L-CARNITINE MAGIS FARMACEUTICI S.P.A. (IT) 1988-04-20 EP claimed
EP-0261627-A2 Process for producing L-arginine KYOWA HAKKO KOGYO CO., LTD. (JP) 1988-03-30 EP claimed
EP-0167115-A2 New derivatives of L-carnitine MAGIS FARMACEUTICI S.P.A. (IT) 1986-01-08 EP claimed
US-3932622-A WATER-IN-OIL EMULSION, DISODIUM OR DIPOTASSIUM SALT OF N-ACETYLGLUTAMTIC ACID GENERAL FOODS CORPORATION (US) 1976-01-13 US claimed